Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
RSVR Quote, Financials, Valuation and Earnings
Last price:
$7.40
Seasonality move
:
-6.85%
Day range:
$7.33 - $7.66
52-week range:
$6.56 - $9.83
Dividend yield:
0%
P/E ratio:
65.15x
P/S ratio:
3.04x
P/B ratio:
1.32x
Volume:
107K
Avg. volume:
88.8K
1-year change:
-9.03%
Market cap:
$480M
Revenue:
$158.7M
EPS (TTM):
$0.11
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $80.2M | $107.8M | $122.3M | $144.9M | $158.7M | |
| Revenue Growth (YoY) | -- | 34.39% | 13.4% | 18.46% | 9.56% | |
| Cost of Revenues | $32.9M | $44.2M | $48M | $55.5M | $57.4M | |
| Gross Profit | $47.4M | $63.7M | $74.3M | $89.4M | $101.3M | |
| Gross Profit Margin | 59.06% | 59.03% | 60.76% | 61.7% | 63.81% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15M | $25.3M | $31.2M | $39.8M | $39.9M | |
| Other Inc / (Exp) | $2.1M | $8.9M | $2.1M | -$2.3M | -$3.3M | |
| Operating Expenses | $29.1M | $44.3M | $53.2M | $64.8M | $66.2M | |
| Operating Income | $18.3M | $19.4M | $21.1M | $24.6M | $35.1M | |
| Net Interest Expenses | $9M | $10.9M | $14.8M | $21.1M | $21.9M | |
| EBT. Incl. Unusual Items | $11.4M | $17.4M | $8.4M | $1.2M | $9.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | $4.3M | $5.6M | $334.8K | $2.1M | |
| Net Income to Company | $9.3M | $13.1M | $2.8M | $837.3K | $7.7M | |
| Minority Interest in Earnings | -$46.7K | -$51.8K | -$240.4K | -$192.3K | $18.5K | |
| Net Income to Common Excl Extra Items | $9.3M | $13.1M | $2.5M | $644.9K | $7.7M | |
| Basic EPS (Cont. Ops) | $0.32 | $0.23 | $0.04 | $0.01 | $0.12 | |
| Diluted EPS (Cont. Ops) | $0.32 | $0.22 | $0.04 | $0.01 | $0.12 | |
| Weighted Average Basic Share | $28.5M | $52.6M | $64.3M | $64.8M | $65.2M | |
| Weighted Average Diluted Share | $28.5M | $58.5M | $64.8M | $65.3M | $65.9M | |
| EBITDA | $34.5M | $47.3M | $45.2M | $47.2M | $58.1M | |
| EBIT | $20.4M | $28.3M | $23.2M | $22.3M | $31.8M | |
| Revenue (Reported) | $80.2M | $107.8M | $122.3M | $144.9M | $158.7M | |
| Operating Income (Reported) | $18.3M | $19.4M | $21.1M | $24.6M | $35.1M | |
| Operating Income (Adjusted) | $20.4M | $28.3M | $23.2M | $22.3M | $31.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $24.1M | $35.1M | $34.8M | $39.1M | $41.4M | |
| Revenue Growth (YoY) | -- | 45.97% | -0.89% | 12.45% | 5.8% | |
| Cost of Revenues | $9M | $13M | $6.9M | $14.3M | $14.2M | |
| Gross Profit | $15M | $22.2M | $28M | $24.8M | $27.2M | |
| Gross Profit Margin | 62.45% | 63.09% | 80.32% | 63.36% | 65.6% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.6M | $8.2M | $8.1M | $9.7M | $10M | |
| Other Inc / (Exp) | $1.4M | $5.9M | -$1.6M | $517.8K | -$1M | |
| Operating Expenses | $8.2M | $13.5M | $13.9M | $16M | $16.7M | |
| Operating Income | $6.8M | $8.7M | $14M | $8.8M | $10.4M | |
| Net Interest Expenses | $2.3M | $2.9M | $4.2M | $5.2M | $6.1M | |
| EBT. Incl. Unusual Items | $5.9M | $11.7M | $2.8M | $4.1M | $3.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $810.3K | $2.8M | $407.2K | $1.2M | $600.1K | |
| Net Income to Company | -- | $8.9M | $2.3M | $2.9M | $2.7M | |
| Minority Interest in Earnings | -$34.6K | $43.7K | -$10.3K | -$56.5K | -$53.6K | |
| Net Income to Common Excl Extra Items | $5M | $8.9M | $2.3M | $2.8M | $2.7M | |
| Basic EPS (Cont. Ops) | $0.23 | $0.14 | $0.04 | $0.04 | $0.04 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.14 | $0.04 | $0.04 | $0.04 | |
| Weighted Average Basic Share | $28.5M | $63.9M | $64.4M | $64.8M | $65.2M | |
| Weighted Average Diluted Share | $28.5M | $64.6M | $65M | $66.8M | $66.1M | |
| EBITDA | $11.8M | $19.8M | $12.7M | $15.7M | $16.2M | |
| EBIT | $8.2M | $14.6M | $6.9M | $9.3M | $9.4M | |
| Revenue (Reported) | $24.1M | $35.1M | $34.8M | $39.1M | $41.4M | |
| Operating Income (Reported) | $6.8M | $8.7M | $14M | $8.8M | $10.4M | |
| Operating Income (Adjusted) | $8.2M | $14.6M | $6.9M | $9.3M | $9.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $107.8M | $122.3M | $144.9M | $158.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $44.2M | $42.5M | $55.5M | $57.4M | |
| Gross Profit | -- | $63.7M | $79.8M | $89.4M | $101.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $25.3M | $31.2M | $39.8M | $39.9M | |
| Other Inc / (Exp) | $2.4M | $8.9M | $2.1M | -$2.3M | -$3.3M | |
| Operating Expenses | -- | $44.3M | $53.2M | $64.8M | $66.2M | |
| Operating Income | -- | $19.4M | $26.5M | $24.6M | $35.1M | |
| Net Interest Expenses | $6.8M | $10.9M | $14.8M | $21.1M | $21.9M | |
| EBT. Incl. Unusual Items | -- | $17.4M | $8.4M | $1.2M | $9.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $4.3M | $5.6M | $334.8K | $2.1M | |
| Net Income to Company | -- | $13.1M | $2.8M | $837.3K | $7.7M | |
| Minority Interest in Earnings | -$105.5K | -$51.8K | -$240.4K | -$192.3K | $18.5K | |
| Net Income to Common Excl Extra Items | -- | $13.1M | $2.5M | $644.9K | $7.7M | |
| Basic EPS (Cont. Ops) | -- | $0.19 | $0.04 | $0.00 | $0.11 | |
| Diluted EPS (Cont. Ops) | -- | $0.19 | $0.04 | $0.00 | $0.11 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | $47.3M | $45.2M | $47.2M | $58.1M | |
| EBIT | -- | $28.3M | $23.2M | $22.3M | $31.8M | |
| Revenue (Reported) | -- | $107.8M | $122.3M | $144.9M | $158.7M | |
| Operating Income (Reported) | -- | $19.4M | $26.5M | $24.6M | $35.1M | |
| Operating Income (Adjusted) | -- | $28.3M | $23.2M | $22.3M | $31.8M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $107.8M | $122.3M | $144.9M | $158.7M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $44.2M | $42.5M | $55.5M | $57.4M | -- | |
| Gross Profit | $63.7M | $79.8M | $89.4M | $101.3M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $25.3M | $31.2M | $39.8M | $39.9M | -- | |
| Other Inc / (Exp) | $8.9M | $2.1M | -$2.3M | -$3.3M | -- | |
| Operating Expenses | $44.3M | $53.2M | $64.8M | $66.2M | -- | |
| Operating Income | $19.4M | $26.5M | $24.6M | $35.1M | -- | |
| Net Interest Expenses | $10.9M | $14.8M | $21.1M | $21.9M | -- | |
| EBT. Incl. Unusual Items | $17.4M | $8.4M | $1.2M | $9.9M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.3M | $5.6M | $334.8K | $2.1M | -- | |
| Net Income to Company | $13.1M | $2.8M | $837.3K | $7.7M | -- | |
| Minority Interest in Earnings | -$51.8K | -$240.4K | -$192.3K | $18.5K | -- | |
| Net Income to Common Excl Extra Items | $13.1M | $2.5M | $644.9K | $7.7M | -- | |
| Basic EPS (Cont. Ops) | $0.19 | $0.04 | $0.00 | $0.11 | -- | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.04 | $0.00 | $0.11 | -- | |
| Weighted Average Basic Share | $210.2M | $257.4M | $259M | $260.6M | -- | |
| Weighted Average Diluted Share | $216.8M | $259M | $261.7M | $263M | -- | |
| EBITDA | $47.3M | $45.2M | $47.2M | $58.1M | -- | |
| EBIT | $28.3M | $23.2M | $22.3M | $31.8M | -- | |
| Revenue (Reported) | $107.8M | $122.3M | $144.9M | $158.7M | -- | |
| Operating Income (Reported) | $19.4M | $26.5M | $24.6M | $35.1M | -- | |
| Operating Income (Adjusted) | $28.3M | $23.2M | $22.3M | $31.8M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.2M | $17.8M | $14.9M | $18.1M | $21.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $15.8M | $25.2M | $31.3M | $33.2M | $37.8M | |
| Inventory | $1.4M | $4M | $5.5M | $6.3M | $4.9M | |
| Prepaid Expenses | $12.8M | $12.4M | $15.2M | $13.2M | $15.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $39.3M | $59.4M | $66.8M | $70.9M | $79.3M | |
| Property Plant And Equipment | $321.8K | $342.1K | $7.9M | $7.5M | $6.4M | |
| Long-Term Investments | $1.6M | $3.9M | $2.3M | $1.5M | $1.1M | |
| Goodwill | -- | $402.1K | $402.1K | $402.1K | $402.1K | |
| Other Intangibles | $391.1M | $571.4M | $617.4M | $640.2M | $719.7M | |
| Other Long-Term Assets | $781.7K | $157.9K | $745.9K | $729.5K | $974.8K | |
| Total Assets | $461.9M | $684.3M | $754.1M | $783.5M | $865.1M | |
| Accounts Payable | $3.3M | $4.4M | $6.7M | $9M | $5.4M | |
| Accrued Expenses | $1.6M | $1.9M | $1.7M | $2M | $2.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $2.6M | $12.3M | $10.6M | $7.3M | $8M | |
| Total Current Liabilities | $25.4M | $41.1M | $54.5M | $60.4M | $65.8M | |
| Long-Term Debt | $211.5M | $269.9M | $311.5M | $330.8M | $388.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $267.5M | $336.8M | $404.4M | $429M | $498.9M | |
| Common Stock | $81.6M | $6.4K | $6.4K | $6.5K | $6.5K | |
| Other Common Equity Adj | $2.1M | -$1.2M | -$4.9M | -$3.8M | -$2.4M | |
| Common Equity | $111.7M | $346.4M | $348.4M | $353M | $364.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1M | $1.1M | $1.3M | $1.5M | $1.3M | |
| Total Equity | $194.4M | $347.5M | $349.7M | $354.5M | $366.2M | |
| Total Liabilities and Equity | $461.9M | $684.3M | $754.1M | $783.5M | $865.1M | |
| Cash and Short Terms | $9.2M | $17.8M | $14.9M | $18.1M | $21.4M | |
| Total Debt | $212.5M | $269.9M | $311.5M | $330.8M | $388.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.2M | $17.8M | $14.9M | $18.1M | $21.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $15.8M | $25.2M | $31.3M | $33.2M | $37.8M | |
| Inventory | $1.4M | $4M | $5.5M | $6.3M | $4.9M | |
| Prepaid Expenses | $12.8M | $12.4M | $15.2M | $13.2M | $15.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $39.3M | $59.4M | $66.8M | $70.9M | $79.3M | |
| Property Plant And Equipment | $321.8K | $342.1K | $7.9M | $7.5M | $6.4M | |
| Long-Term Investments | $1.6M | $3.9M | $2.3M | $1.5M | $1.1M | |
| Goodwill | -- | $402.1K | $402.1K | $402.1K | $402.1K | |
| Other Intangibles | $391.1M | $571.4M | $617.4M | $640.2M | $719.7M | |
| Other Long-Term Assets | $781.7K | $157.9K | $745.9K | $729.5K | $974.8K | |
| Total Assets | $461.9M | $684.3M | $754.1M | $783.5M | $865.1M | |
| Accounts Payable | $3.3M | $4.4M | $6.7M | $9M | $5.4M | |
| Accrued Expenses | $1.6M | $1.9M | $1.7M | $2M | $2.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $2.6M | $12.3M | $10.6M | $7.3M | $8M | |
| Total Current Liabilities | $25.4M | $41.1M | $54.5M | $60.4M | $65.8M | |
| Long-Term Debt | $211.5M | $269.9M | $311.5M | $330.8M | $388.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $267.5M | $336.8M | $404.4M | $429M | $498.9M | |
| Common Stock | $81.6M | $6.4K | $6.4K | $6.5K | $6.5K | |
| Other Common Equity Adj | $2.1M | -$1.2M | -$4.9M | -$3.8M | -$2.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1M | $1.1M | $1.3M | $1.5M | $1.3M | |
| Total Equity | $194.4M | $347.5M | $349.7M | $354.5M | $366.2M | |
| Total Liabilities and Equity | $461.9M | $684.3M | $754.1M | $783.5M | $865.1M | |
| Cash and Short Terms | $9.2M | $17.8M | $14.9M | $18.1M | $21.4M | |
| Total Debt | $212.5M | $269.9M | $311.5M | $330.8M | $388.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.3M | $13.1M | $2.8M | $837.3K | $7.7M | |
| Depreciation & Amoritzation | $14.1M | $19M | $22.1M | $25M | $26.3M | |
| Stock-Based Compensation | $102.7K | $2.9M | $3.2M | $3.4M | $4.4M | |
| Change in Accounts Receivable | -$6.1M | -$9.4M | -$6M | -$2M | -$4.6M | |
| Change in Inventories | -$975.4K | -$2.6M | -$1.4M | -$842.4K | -- | |
| Cash From Operations | $14.7M | $12.5M | $31.2M | $36.2M | $45.3M | |
| Capital Expenditures | $118.6M | $194.4M | $72.2M | $50.4M | $96.6M | |
| Cash Acquisitions | -$13.4K | -$2.5M | -- | -$200K | -$1.1M | |
| Cash From Investing | -$118.6M | -$196.8M | -$72.2M | -$50.6M | -$96.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $40.9M | $214.5M | $42.2M | $34M | $66M | |
| Long-Term Debt Repaid | -$1M | -$154.7M | -- | -$16M | -$10M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$648.8K | $136.8M | -$4M | -$728.5K | -$1.6M | |
| Cash From Financing | $47.2M | $196.5M | $38.5M | $17.6M | $54.5M | |
| Beginning Cash (CF) | $58.2M | $9.2M | $17.8M | $14.9M | $18.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$56.7M | $12.2M | -$2.6M | $3.2M | $3.1M | |
| Ending Cash (CF) | $9.2M | $17.8M | $14.9M | $18.1M | $21.4M | |
| Levered Free Cash Flow | -$103.9M | -$181.9M | -$41M | -$14.2M | -$51.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $8.9M | $2.3M | $2.9M | $2.7M | |
| Depreciation & Amoritzation | -- | $5.3M | $5.8M | $6.4M | $6.8M | |
| Stock-Based Compensation | -- | $1.5M | $794K | $846.4K | $1.1M | |
| Change in Accounts Receivable | -- | -$6.7M | -$4.4M | -$2.6M | -$3.2M | |
| Change in Inventories | -- | $501.2K | $396.2K | -- | -- | |
| Cash From Operations | -- | -$372.7K | $5M | $13.8M | $12.2M | |
| Capital Expenditures | -- | $38.2M | $26.8M | $3.4M | $26.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -$1M | |
| Cash From Investing | -- | -$38.2M | -$26.8M | -$3.4M | -$24.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $44M | $19M | -- | $16M | |
| Long-Term Debt Repaid | -- | -- | -- | -$12M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$20 | -- | -- | |
| Cash From Financing | -- | $44M | $19.2M | -$12M | $16M | |
| Beginning Cash (CF) | -- | $14.6M | $17M | $19.5M | $17.8M | |
| Foreign Exchange Rate Adjustment | -- | -$2.2M | $468.9K | $203.9K | $238K | |
| Additions / Reductions | -- | $5.4M | -$2.6M | -$1.6M | $3.4M | |
| Ending Cash (CF) | -- | $17.8M | $14.9M | $18.1M | $21.4M | |
| Levered Free Cash Flow | -- | -$38.6M | -$21.8M | $10.4M | -$14.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $13.1M | $2.8M | $837.3K | $7.7M | |
| Depreciation & Amoritzation | -- | $19M | $22.1M | $25M | $26.3M | |
| Stock-Based Compensation | -- | $2.9M | $3.2M | $3.4M | $4.4M | |
| Change in Accounts Receivable | -- | -$9.4M | -$6M | -$2M | -$4.6M | |
| Change in Inventories | -- | -$2.6M | -$1.4M | -$842.4K | -- | |
| Cash From Operations | -- | $12.5M | $31.2M | $36.2M | $45.3M | |
| Capital Expenditures | -- | $194.4M | $72.2M | $50.4M | $96.6M | |
| Cash Acquisitions | -- | -$2.5M | -- | -$200K | -$1.1M | |
| Cash From Investing | -- | -$196.8M | -$72.2M | -$50.6M | -$96.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $214.5M | $42.2M | $34M | $66M | |
| Long-Term Debt Repaid | -- | -$154.7M | -- | -$16M | -$10M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$4M | -$728.5K | -$1.6M | |
| Cash From Financing | -- | $196.5M | $38.5M | $17.6M | $54.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $12.2M | -$2.6M | $3.2M | $3.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$181.9M | -$41M | -$14.2M | -$51.3M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $13.1M | $2.8M | $837.3K | $7.7M | -- | |
| Depreciation & Amoritzation | $19M | $22.1M | $25M | $26.3M | -- | |
| Stock-Based Compensation | $2.9M | $3.2M | $3.4M | $4.4M | -- | |
| Change in Accounts Receivable | -$9.4M | -$6M | -$2M | -$4.6M | -- | |
| Change in Inventories | -$2.6M | -$1.4M | $0 | $0 | -- | |
| Cash From Operations | $12.5M | $31.2M | $36.2M | $45.3M | -- | |
| Capital Expenditures | $194.4M | $72.2M | $50.4M | $96.6M | -- | |
| Cash Acquisitions | -$2.5M | -- | -$200K | -$1.1M | -- | |
| Cash From Investing | -$196.8M | -$72.2M | -$50.6M | -$96.7M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $214.5M | $42.2M | $34M | $66M | -- | |
| Long-Term Debt Repaid | -$154.7M | -- | -$16M | -$10M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $136.8M | -$4M | -$728.5K | -$1.6M | -- | |
| Cash From Financing | $196.5M | $38.5M | $17.6M | $54.5M | -- | |
| Beginning Cash (CF) | $50.6M | $66.2M | $67.2M | $73.3M | -- | |
| Foreign Exchange Rate Adjustment | -$3.6M | -$346.9K | $30.7K | $175.3K | -- | |
| Additions / Reductions | $12.2M | -$2.6M | $3.2M | $3.1M | -- | |
| Ending Cash (CF) | $59.2M | $63.3M | $70.5M | $76.6M | -- | |
| Levered Free Cash Flow | -$181.9M | -$41M | -$14.2M | -$51.3M | -- | |
Get RSVR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RSVR
Sector
P/E ratio
65.15x
17.70x
PEG ratio
0.03x
0.00x
P/B ratio
1.32x
1.49x
Price / LTM sales
3.04x
0.96x
Growth Metrics
RSVR
Sector
Revenue growth
5.8%
-0.53%
Earnings growth
--
-0.61%
Revenue (5-year growth)
--
1.59%
Earnings forecast
$0.13
$0.05
Profitability
RSVR
Sector
Profitability FY 2024
$101.3M
$256.3M
Return on invested capital
1.1%
0.79%
Return on assets
0.96%
0.12%
Return on equity
2.16%
2.1%
Earnings Date
Last Earnings Date
May
28
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Aug
27
Balance Sheet
RSVR
Sector
Total cash
$21.4M
$97.1M
Short term investments
--
$26.8M
Total assets
$865.1M
$827.5M
Long term debt
$388.1M
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
